Grown Rogue International (GRUSF) Change in Working Capital (2012 - 2025)

Grown Rogue International's (GRUSF) quarterly Change in Working Capital came in at -$2131.2 billion in Q3 2025, down 326.9% year-on-year from $939.2 billion in Q3 2024, and down 312577055.81% quarter-over-quarter from $681808.0 in Q2 2025.

Grown Rogue International (GRUSF) Change in Working Capital (2012 - 2025) Analysis & Trends

Grown Rogue International's Change in Working Capital history runs 13 years deep, the most recent figure standing at -$2131.2 billion for Q3 2025.

  • On a quarterly basis, Change in Working Capital fell 326.9% year-over-year to -$2131.2 billion in Q3 2025; TTM through Sep 2025 was -$3070.4 billion, a 426.9% decrease from a year earlier, with the FY2024 full-year figure at $1.4 million, up 371.64% from the prior year.
  • Change in Working Capital eased to -$2131.2 billion in Q3 2025 per GRUSF's latest filing, from $681808.0 in the prior quarter.
  • Across five years, Change in Working Capital topped out at $939.2 billion in Q3 2024 and bottomed at -$2131.2 billion in Q3 2025.
  • The 5-year median for Change in Working Capital is -$404466.5 (2022), against an average of -$133.2 billion.
  • Across the five-year window, Change in Working Capital retreated 7.61% in 2023 and plunged 371.19% in 2025, its largest moves.
  • Year by year, Change in Working Capital stood at -$286562.0 in 2021, then sank by 35.97% to -$389648.0 in 2022, then jumped by 33.82% to -$257878.0 in 2023, then tumbled by 364218874.05% to -$939.2 billion in 2024, then plunged by 126.9% to -$2131.2 billion in 2025.
  • Per Business Quant, the three latest GRUSF Change in Working Capital figures stand at -$2131.2 billion (Q3 2025), $681808.0 (Q2 2025), and -$2.0 million (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -617.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -2,131.17 Bn
Sep 30, 2025 -2,131.17 Bn
Jun 30, 2025 681,808.00
Jun 30, 2025 681,808.00
Mar 31, 2025 -1.99 Mn
Mar 31, 2025 -1.99 Mn
Dec 31, 2024 -939.24 Bn
Dec 31, 2024 -939.24 Bn
Sep 30, 2024 939.24 Bn
Sep 30, 2024 939.24 Bn
Jun 30, 2024 847,618.00
Jun 30, 2024 847,618.00
Mar 31, 2024 -422,527.00
Mar 31, 2024 -422,527.00
Oct 31, 2023 -257,878.00
Oct 31, 2023 -257,878.00
Jul 31, 2023 -784,047.00
Jul 31, 2023 -784,047.00
Apr 30, 2023 -284,131.00
Apr 30, 2023 -284,131.00